4
Changes in Ownership
NovaBridge Biosciences Filed Acc 0002089237-26-000006
Chief Medical Officer sold 8,494 shares at $0.66 ($5,606)
- Chief Medical Officer acquired 23,695 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dennis Phillip Andrew Chief Medical Officer | 2026-06-17 | Option exercise | +23,695 | 166,435 | D: show line 1 in the form | ||
| Dennis Phillip Andrew Chief Medical Officer | 2026-06-18 | Sale | −8,494 | $0.66 | $5,606 | 157,941 | D: show line 2 in the form |
| Open-market sales · 8,494 sh · avg $0.66 · $5,606 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Dennis Phillip Andrew Chief Medical Officer | 2026-06-17 | Option exercise · Restricted Share Units | −10,302 | 82,422 | D: show line 3 in the form |
Loading xslF345X06/form4-06222026_090646.xml…